Lupin informs about press release

01 Oct 2025 Evaluate
Lupin has informed that it enclosed a Press Release as regards, launch of Rivaroxaban for Oral Suspension, 1 mg/mL, in the United States.

The above information is a part of company’s filings submitted to BSE. 

Lupin Share Price

2112.95 3.95 (0.19%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×